Effects of Ethyl Acetate Leaf Extract of Annona muricata on some Enzymes of Carbohydrate Metabolism in Streptozotocin-Induced Diabetic Wistar Rats
DOI:
https://doi.org/10.2659/njbmb.2022.54Abstract
Diabetes is a chronic metabolic disease of multiple etiologies characterized by high blood sugar levels. The management of diabetes is taken as a global problem and curative treatment is yet to be uncovered. The leaf, root and bark of Annona muricata have been reportedly used locally as an antidiabetic agent. This study aimed to evaluate the effects of ethylacetate leaf extract of Annona muricata (AMLE) on selected enzymes of carbohydrate metabolism in diabetic rat model. Twenty male rats weighing 180 to 220 g were randomly assigned into four groups. Groups A and B were non-diabetic and diabetic rats respectively, treated with 5% dimethyl sulfoxide saline respectively. Groups C and D were diabetic rats treated with 200mg/kg body weight (b.wt) AMLE and 5 mg/kg b.wt glibenclamide respectively for 14 days. Diabetes was induced by a single dose of 45 mg/kg b.wt streptozotocin (STZ) intraperitoneally. Rats with blood glucose values above 13.9 mmol/l 48 hours after STZ injection were considered diabetic. Animals were sacrificed on day 15 and hepatic activities of glucose-6-phosphate dehydrogenase, glucokinase, glucose-6-phosphatase and lactate dehydrogenase were assayed. The levels of hepatic lactate dehydrogenase, glucose-6-phosphate dehydrogenase and glucokinase activities in AMLE treated diabetic rats were significantly (p˂0.05) reduced compared to untreated diabetic rats. However, the activity of glucose-6-phosphatase was only slightly inhibited in the diabetic rats treated with AMLE. Ethylacetate leaf extract of A. muricata inhibited the activities of glucose-6-phosphatase and lactate dehydrogenase in this study. These findings partially support the use of this plant in the treatment of diabetes.
References
Adewole, S.O. and Caxton-Martins, E.A. (2006). Morphological changes and hypoglycemic effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on pancreatic B-cells of streptozotocin-treated diabetic rats. African Journal of Biomedical Research, 9(3), 173-187.
Agius L (2008). Glucokinase and molecular aspects of liver glycogen metabolism. Biochemical Journal. 414(1):1–18
Cornish-Bowden, A., and Cardenas, M. L. (2004). Glucokinase: a monomeric enzyme with positive cooperativity. Glucokinase and glycemic disease: From Basics to Novel Therapeutics, 125–134. doi:10.1159/000079011
Das, K., Tiwari, R.K.S. and Shrivastava, D.K. (2010). Techniques for evaluation of medicinal plant products as antimicrobial agent: current methods and future trends. Journal of Medicinal Plants Research, 4(2), 104-111.
Dey, L., Attele, A.S. and Yuanm C.S. (2002). Alternative therapies for type 2 diabetes. Alternative Medicine Review, 7(1), 45-58.
Eid, A., Bodin, S., Ferrier, B., Delage, H., Boghossian, M., Martin, M., Baverel, G. and Conjard, A. (2006). Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats. Journal of the American Society of Nephrology 17(2), 398–405.
Fava, S. (2008). Role of postprandial hyperglycemia in cardiovascular disease. Expert Review in Cardiovascular Therapy. 6(6), 859-872.
Gupta, B. L., Nehal, M. and Baquer, N. Z. (1997). Effect of experimental diabetes on the activities of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages. Indian Journal of Experimental Biology, 35(7), 792–795.
Lawal, Z. A., hamid, A.A., Shehu, A., God’shelp, E., Ajibade, O. S., Zubair, O. A., Ogheneovo, P., Mukadam, A. A. and Adebayo, C. T. (2017). Biochemical properties, in-vitro antimicrobial, and free radical scavenging activities of the leaves of Annona muricata. Journal of Applied Sciences and Environmental Management, 21(6), 1197-1201.
Matschinsky FM (2009). Assessing the potential of glucokinase activators in diabetes therapy. Nature Reviews Drug Discovery. 8(5):399–416
Matschinsky, F.M., Liang, Y., Kesavan, P., Wang, L., Froguel, P., Velho, G., et al. (1993). Glucolinase as pancreatic B-cell sensor and diabetes gene. Journal of Clinical Investigation. 92, 2092-2098. Doi:10.1172/JC1116809
Oscar A, Markus T and Sigurd (2000). Importance of lactate dehydrogenase for the regulation of glycolytic flux and insulin secretion in insulin-producing cells. Biochemical Journal, 352(2), 373–. doi:10.1042/0264-6021:3520373.
Pozzilli, A., Signore, R. D. G., Leslie K., Alberti, P., Zimmet, R. and De Fronzo, H. (1997). “Infections, immunity and diabetes,” in International Text Book of Diabetes Mellitus. Eds., pp. 1231–1241, 2nd edition, 1997.
Prentki, M., Tornheim, K. and Corkey, B. E. (1997). Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia, 40 Suppl 2, S32–S41. https://doi.org/10.1007/s001250051395
Rotenstein, L.S., Kozak, B.M., Shivers, J.P., Yarchoan, M., Close, J. and Close, K.L. (2012). The ideal diabetes therapy: Clinical Diabetes, 30(2), 44–53.
Sekine, N., Cirulli, V., Regazzi, R., Brown, L. J., Gine, E., Tamarit-Rodriguez, J.,
Girotti, M., Marie, S., MacDonald, M. J., Wollheim, C. B. and Rutter, G.A. (1994). Low lactate
dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in
pancreatic beta-cells. Potential role in nutrient sensing. Journal of Biological Chemistry, 269(7), 4895–4902.
Srinivasan, K. and Ramarao, P. (2007). Animal models in type 2 diabetes research: an overview. The Indian Journal of Medical Research, 125(3), 451–472.
Van de Werve, G., Lange, A., Newgard, C., Méchin, M. C., Li, Y. and Berteloot, A. (2000). New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system. European Journal of Biochemistry, 267(6), 1533–1549. doi:10.1046/j.1432-1327.2000.01160.x
Vulliamy, T., Mason, P. and Luzzatto, L. (1992). The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends in Genetics 8(4), 138–143. https://doi.org/10.1016/0168-9525(92)90372-B
Wallace, T.M. and Matthews, D.R. (2000). Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. Quarterly Journal of Medicine, 93(6), 369–374.
World Health Organization (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus, Geneva.
World Health Organization-Diabetes Fact Sheets, 2020
Wua, C., Li, Y., Chena, Y., Laoa, X., Shenga, L. and Daia, R. (2011). Hypoglycemic effect of Belamcanda chinensis leaf extract in normal and STZ-induced diabetic rats and its potential active faction. Phytomedicine; 18(4), 292-297.
Zhang, X., Liang, W., Mao, Y., Li, H., Yang, Y. and Tan, H. (2009). Hepatic glucokinase activity is the primary defect in alloxan-induced diabetes of mice. Biomedicine and Pharmacotherapy, 63(3), 180–186. https://doi.org/10.1016/j.biopha.2007.07.006
Zhang, Z., Apse, K., Pang, J. and Stanton, R. C. (2000). High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. The Journal of Biological Chemistry, 275(51), 40042–40047. https://doi.org/10.1074/jbc.M007505200
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Abubakar Zubair LAWAL, H.A Abdulrahim, A.I Yusuf, M. Ibrahim, A.S Adekunle,
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.